Chemotherapy-Free, Immunotherapy-Based Treatment - First of Its Kind - Improves Survival for Patients With Colorectal Cancer
October 21, 2025
October 21, 2025
PITTSBURGH, Pennsylvania, Oct. 21 -- The University of Pittsburgh Medical Center issued the following news release:
* * *
Chemotherapy-Free, Immunotherapy-Based Treatment - First of its Kind - Improves Survival for Patients with Colorectal Cancer
A clinical trial, led by UPMC Hillman Cancer Center, is the first to show that an immunotherapy-based, chemotherapy-free treatment can extend the lives of people with metastatic colorectal cancer who have exhausted . . .
* * *
Chemotherapy-Free, Immunotherapy-Based Treatment - First of its Kind - Improves Survival for Patients with Colorectal Cancer
A clinical trial, led by UPMC Hillman Cancer Center, is the first to show that an immunotherapy-based, chemotherapy-free treatment can extend the lives of people with metastatic colorectal cancer who have exhausted . . .